Oral iloprost as a treatment for Raynaud's syndrome: a double blind multicentre placebo controlled study

OBJECTIVE--To compare the efficacy, tolerance and safety of 50-150 micrograms orally administered iloprost given twice a day versus placebo in patients with Raynaud's syndrome. METHODS--The study was multicentre (n = 3), double blind and placebo controlled. Sixty three patients who had eight or...

Ausführliche Beschreibung